2 Einträge gefunden

1. Ustekinumab decreases work limitations, improves work productivity, and reduces work days missed in patients with moderate-to-severe psoriasis: Results from PHOENIX 2.

   1. Reich, Kristian
   2. Schenkel, Brad
   3. Zhao, Ning
   4. Szapary, Philippe
   5. Augustin, Matthias
   6. Bourcier, Marc
   7. Guenther, Lyn

   2011 - Forschungsinformationssystem des UKE
2. Cost per responder analysis of ustekinumab and etanercept for moderate to severe plaque psoriasis.

   1. Martin, Silas
   2. Feldman, Steven R
   3. Augustin, Matthias
   4. Szapary, Philippe
   5. Schenkel, Brad

   2011 - Forschungsinformationssystem des UKE